This site is intended for healthcare professionals
Login | Register (NOW FREE)

Medical search

brain tumour ( ependymoma)

FREE subscriptions for doctors and students... click here
You have 3 open access pages.

The group of brain tumours called gliomas includes:

  • astrocytomas
  • glioblastoma multiforme
  • oligodendrogliomas
  • ependymomas

They are the most common primary tumour of the cerebral hemisphere in adults and children. They are usually highly malignant and carry a poor prognosis. The vast majority - approximately 90% - occur in either the frontal, parietal or temporal lobe. Other possible sites include the thalamus, corpus callosum or occipital lobe.

  • gliomas are graded according to their likely rate of growth, from grade 1 (slowest growing) to grade 4 (fastest growing)
    • grade 3 and 4 gliomas are considered high-grade gliomas
    • grade 3 gliomas include anaplastic astrocytoma, anaplastic ependymoma, anaplastic oligodendroglioma and anaplastic oligoastrocytoma
    • grade 4 gliomas are usually glioblastoma multiforme (GBM)

  • symptoms of high-grade glioma depend on the size, location and degree of infiltration of the tumour
    • possible symptoms include headache, nausea, vomiting, seizures, visual disturbance, speech and language problems, and changes in cognitive and/or functional ability

  • diagnosis of high-grade glioma is provisionally made through a computed tomography (CT) scan or MRI
    • diagnosis is then confirmed and the tumour classified histologically, either at the time of surgical resection or by a single-event biopsy if surgery is not possible

  • treatment usually consists of surgical resection where possible, followed by radiotherapy
    • surgery may achieve either complete resection or partial resection of the tumour
    • radiotherapy has been demonstrated to prolong survival and is usually recommended after surgery
    • adjuvant chemotherapy may be indicated

  • approximately 30% of adults with high-grade gliomas survive for at least 1 year, and 13% survive for 5 years
    • median survival of patients with anaplastic astrocytoma is around 2-3 years, and that of patients with GBM is approximately 1 year
    • age, performance status and tumour histology are indicators of pretreatment prognosis
      • patients with high-grade gliomas have a better prognosis if they are younger, have a better performance status, or have a grade 3 tumour


  • brain tumours account for fewer than 2% of all primary cancers.


  1. NICE (June 2007). Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma
  2. NICE (July 2018). Brain tumours (primary) and brain metastases in adults


The information provided herein should not be used for diagnosis or treatment of any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions. Copyright 2016 Oxbridge Solutions LtdĀ®. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions LtdĀ® receives funding from advertising but maintains editorial independence. GPnotebook stores small data files on your computer called cookies so that we can recognise you and provide you with the best service. If you do not want to receive cookies please do not use GPnotebook.